Published in

Bentham Science Publishers, Current Drug Delivery, (15)

DOI: 10.2174/1567201815666180518125839

Links

Tools

Export citation

Search in Google Scholar

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

Journal article published in 2018 by Romeo Ngoune, Christine Contini, Dominik von Elverfeldt ORCID, Michael Marcus Hoffmann, Dominik Elverfeldt, Karl Winkler, Gerhard Putz
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO